Male Contraception Initiative RFA is Now Open

google_plustwitterFacebookmail

MCI’s 2019 FRA is open for submission. This funding will support research in reversible, non-hormonal male contraceptive discovery and development. MCI intends to fund up to five grants, ranging from $150,000 to $300,000 over two years. MCI’s Priority Research Areas include:

● Post-meiotic phase of spermatogenesis
● Sperm functions required for normal fertilization, such as sperm motility and the
acrosome reaction
● Post-testicular processes required for fertility, including epididymal maturation and sperm
transport in the excurrent ducts
● Other processes that lead to fast-acting, reversible male contraceptives
● The potential for Multipurpose Prevention Technology (MPT) products acting against
sexually transmitted infections

Application are due by May 31, 2019. Additional information and the application can be found here.

google_plustwitterFacebookmail

Categorised in: Acceptability & Product Design, Funders, Funding, Male Contraception, Methods

Leave a Reply

Your email address will not be published. Required fields are marked *